|
|
|
Insider
Information: |
Quimi Daphne |
Relationship: |
|
City: |
Cranbury |
State: |
NJ |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
2 |
|
Direct
Shares |
403,532 |
|
Indirect Shares
|
0 |
|
|
Direct
Value |
$4,228,425 |
|
|
Indirect Value
|
$0 |
|
|
Total
Shares |
403,532 |
|
|
Total
Value |
$4,228,425 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Amicus Therapeutics Inc |
FOLD |
Chief Financial Officer |
2023-01-18 |
398,532 |
2014-04-10 |
0 |
Premium* |
|
Amylyx Pharmaceuticals, Inc. |
AMLX |
|
2024-05-15 |
5,000 |
2024-05-14 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
80 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 4
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
FOLD |
Amicus Therapeutics Inc |
Chief Financial Officer |
|
2019-06-17 |
4 |
D |
$11.35 |
$11,872 |
D/D |
(1,046) |
129,254 |
0 |
- |
|
FOLD |
Amicus Therapeutics Inc |
Chief Financial Officer |
|
2020-06-15 |
4 |
D |
$11.14 |
$11,652 |
D/D |
(1,046) |
194,179 |
0 |
- |
|
FOLD |
Amicus Therapeutics Inc |
Chief Financial Officer |
|
2022-01-03 |
4 |
D |
$12.11 |
$18,625 |
D/D |
(1,538) |
262,811 |
0 |
- |
|
AMLX |
Amylyx Pharmaceuticals, I... |
|
|
2024-05-15 |
4 |
B |
$1.89 |
$4,252 |
D/D |
2,250 |
5,000 |
0.01 |
- |
|
FOLD |
Amicus Therapeutics Inc |
Vice President Finance |
|
2015-09-14 |
4 |
AS |
$18.08 |
$45,200 |
D/D |
(2,500) |
5,688 |
0 |
- |
|
FOLD |
Amicus Therapeutics Inc |
Vice President Finance |
|
2015-07-01 |
4 |
OE |
$13.98 |
$36,350 |
D/D |
2,600 |
10,788 |
0 |
- |
|
FOLD |
Amicus Therapeutics Inc |
Vice President Finance |
|
2015-07-01 |
4 |
AS |
$13.98 |
$36,350 |
D/D |
(2,600) |
8,188 |
0 |
- |
|
FOLD |
Amicus Therapeutics Inc |
Chief Financial Officer |
|
2020-12-31 |
4 |
D |
$23.09 |
$60,496 |
D/D |
(2,620) |
241,724 |
0 |
- |
|
AMLX |
Amylyx Pharmaceuticals, I... |
|
|
2024-05-14 |
4 |
B |
$1.89 |
$5,184 |
D/D |
2,750 |
2,750 |
0.01 |
- |
|
FOLD |
Amicus Therapeutics Inc |
SVP, Finance |
|
2016-11-09 |
4 |
OE |
$8.00 |
$22,864 |
D/D |
2,858 |
27,047 |
0 |
- |
|
FOLD |
Amicus Therapeutics Inc |
SVP, Finance |
|
2018-01-03 |
4 |
D |
$15.67 |
$46,274 |
D/D |
(2,953) |
64,332 |
0 |
- |
|
FOLD |
Amicus Therapeutics Inc |
VP Finance and Controller |
|
2014-11-25 |
4 |
AS |
$8.00 |
$28,000 |
D/D |
(3,500) |
50,000 |
0 |
- |
|
FOLD |
Amicus Therapeutics Inc |
VP Finance and Controller |
|
2014-11-25 |
4 |
AB |
$8.00 |
$28,000 |
D/D |
3,500 |
53,500 |
0 |
- |
|
FOLD |
Amicus Therapeutics Inc |
Chief Financial Officer |
|
2019-01-03 |
4 |
D |
$10.33 |
$39,771 |
D/D |
(3,850) |
117,953 |
0 |
- |
|
FOLD |
Amicus Therapeutics Inc |
Chief Financial Officer |
|
2022-01-04 |
4 |
D |
$12.48 |
$50,432 |
D/D |
(4,041) |
331,906 |
0 |
- |
|
FOLD |
Amicus Therapeutics Inc |
Chief Financial Officer |
|
2020-12-15 |
4 |
D |
$23.86 |
$99,162 |
D/D |
(4,156) |
244,344 |
0 |
- |
|
FOLD |
Amicus Therapeutics Inc |
Chief Financial Officer |
|
2022-06-17 |
4 |
AS |
$9.00 |
$39,564 |
D/D |
(4,396) |
345,507 |
0 |
- |
|
FOLD |
Amicus Therapeutics Inc |
Chief Financial Officer |
|
2022-09-01 |
4 |
AS |
$11.29 |
$49,621 |
D/D |
(4,397) |
335,312 |
0 |
- |
|
FOLD |
Amicus Therapeutics Inc |
Chief Financial Officer |
|
2021-03-05 |
4 |
D |
$10.48 |
$48,879 |
D/D |
(4,664) |
271,334 |
0 |
- |
|
FOLD |
Amicus Therapeutics Inc |
Chief Financial Officer |
|
2021-01-15 |
4 |
D |
$21.84 |
$104,153 |
D/D |
(4,770) |
259,370 |
0 |
- |
|
FOLD |
Amicus Therapeutics Inc |
Chief Financial Officer |
|
2020-04-01 |
4 |
A |
$0.00 |
$0 |
D/D |
4,803 |
195,225 |
0 |
- |
|
FOLD |
Amicus Therapeutics Inc |
Chief Financial Officer |
|
2020-10-01 |
4 |
AS |
$14.02 |
$70,099 |
D/D |
(5,000) |
207,179 |
0 |
- |
|
FOLD |
Amicus Therapeutics Inc |
Chief Financial Officer |
|
2020-10-01 |
4 |
OE |
$2.94 |
$14,700 |
D/D |
5,000 |
212,179 |
0 |
- |
|
FOLD |
Amicus Therapeutics Inc |
Chief Financial Officer |
|
2020-12-21 |
4 |
OE |
$2.94 |
$14,700 |
D/D |
5,000 |
249,344 |
0 |
- |
|
FOLD |
Amicus Therapeutics Inc |
Chief Financial Officer |
|
2020-12-21 |
4 |
AS |
$24.09 |
$120,474 |
D/D |
(5,000) |
244,344 |
0 |
- |
|
80 Records found
|
|
Page 1 of 4 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|